Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M73.9Revenue (TTM) $M4.7Net Margin (%)-482.4Altman Z-Score-17.9
Enterprise Value $M42.0EPS (TTM) $-0.3Operating Margin %-486.2Piotroski F-Score2
P/E(ttm)--Beneish M-Score-3.0Pre-tax Margin (%)-482.4Higher ROA y-yN
Price/Book2.910-y EBITDA Growth Rate %-17.5Quick Ratio3.7Cash flow > EarningsN
Price/Sales14.35-y EBITDA Growth Rate %11.2Current Ratio3.7Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-55.7Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-71.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M71.2ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ARQL

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

ARQL is held by these investors:

ARQL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LOBERG MICHAEL DDirector 2015-12-17Buy3,719$2.16-55.09view
LOBERG MICHAEL DDirector 2015-12-16Buy1,231$2.14-54.67view
Pucci PaoloCEO 2015-12-15Buy1,283$2.16-55.09view
Pucci PaoloCEO 2015-12-11Buy1,108$2.1-53.81view
ZENNER PATRICK JDirector 2015-12-11Buy2,300$2.15-54.88view
Pucci PaoloCEO 2015-12-10Buy7,609$2.1-53.81view
ZENNER PATRICK JDirector 2015-03-11Buy10,625$2.32-58.19view
Pucci PaoloCEO 2014-11-20Buy5,000$1.26-23.02view
ZENNER PATRICK JDirector 2014-11-14Buy20,830$1.2-19.17view
Messenger William GDirector 2014-11-14Buy8,500$1.21-19.83view

Quarterly/Annual Reports about ARQL:

News about ARQL:

Articles On GuruFocus.com
Jean-Marie Eveillard Increases Stakes in Cancer Therapeutics Company Arqule Inc May 05 2015 
Jean-Marie Eveillard Adds to Stake in Arqule Inc. May 03 2015 
ArQule Inc. Reports Operating Results (10-Q) Nov 09 2010 
ArQule Inc. Reports Operating Results (10-Q) Aug 04 2010 
ArQule Inc. Reports Operating Results (10-Q) May 06 2010 
ArQule Inc. (ARQL) CEO Paolo Pucci buys 5,000 Shares Nov 13 2009 
ArQule Inc. Reports Operating Results (10-Q) Aug 07 2009 
ArQule Inc. (ARQL) CEO Paolo Pucci buys 2,500 Shares May 15 2009 
ArQule Inc. Reports Operating Results (10-Q) May 08 2009 

More From Other Websites
ArQule To Report First Quarter 2017 Financial Results On May 3, 2017 Apr 19 2017
ArQule Receives Clearance of Investigational New Drug Application from the FDA for Proprietary... Apr 11 2017
ETFs with exposure to ArQule, Inc. : April 5, 2017 Apr 05 2017
ArQule to Present at the 16th Annual Needham Healthcare Conference on April 4, 2017 Mar 28 2017
ArQule Announces Top-Line Results of Phase 3 Clinical Study of Tivantinib in Hepatocellular... Mar 27 2017
ArQule, Inc. :ARQL-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017 Mar 21 2017
ArQule, Inc. :ARQL-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017 Mar 14 2017
Edited Transcript of ARQL earnings conference call or presentation 7-Mar-17 2:00pm GMT Mar 07 2017
ArQule reports 4Q loss Mar 07 2017
ArQule Reports Fourth Quarter and Full Year 2016 Financial Results Mar 07 2017
ArQule To Report Fourth Quarter and Year End 2016 Financial Results On March 7, 2017 Feb 24 2017
ArQule Liver Cancer Drug Fails Phase 3 Trial Feb 20 2017
ArQule, Inc. (ARQL)’s Liver Cancer Drug Fails: What’s Next? Feb 20 2017
Sabre Corp., L Brands Dip into Friday’s 52-Week Low Club Feb 17 2017
Daiichi Sankyo and ArQule Announce the Completion of the METIV-HCC Phase 3 Study of Tivantinib in... Feb 17 2017
ArQule to Present at The Leerink Partners 6th Annual Global Healthcare Conference on February 15,... Feb 08 2017
ArQule (ARQL) Catches Eye: Stock Moves 7.2% Higher Jan 13 2017
The Life Sciences Report Announces 19 Companies Selected for the 2017 Small-Cap Biotech Watchlist Jan 05 2017
ETFs with exposure to ArQule, Inc. : December 21, 2016 Dec 21 2016
How ArQule, Inc. (ARQL) Stacks Up Against Its Peers Dec 20 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)